EP3239163A1 - A NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN-3,25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVER DISEASES AND ATHEROSCLEROSIS